Screening antiangiogenic effects of different FDA approved drugs using vascular endothelial cells tube formation technique

ZHANG Bo,WU Guo-hao,JIN Da-yong,WU Zhao-han,QIN Xin-yu

DOI: https://doi.org/10.3969/j.issn.1672-8467.2006.03.023

2006-01-01

Abstract:Purpose To investigate the antiangiogenic effect of different FDA approved drugs. Methods In vitro cultured human umbilical vein endothelial cell(HUVEC) can form micro-vascular structures on the surface of Matrigel matrix.We added different FDA drugs of very low dose in the medium to detect their inhibitory effects on this micro-vascular forming ability by counting the total length of the tubes formed and compared to those in control groups. Results Avandia had no effect at concentration from 0.1-1 μmol.Doxycycline presented no effect at concentration from 0.1-10 μg/mL.NAC did not inhibit tube formation at concentration from 100 μg/mL-1 mg/mL.Rapamycin had no effect at concentration from 1-10 ng/mL(24-48 hrs pretreatment).NS398 had some inhibition effect at concentration from 0.5-50 μg/mL,at 50 μg/mL it presented 56% inhibition effect compared to normal control.Suramin presented strong inhibitory effect at concentration from 20-50 μg/mL(30 μg/mL 57% inhibition,40 μg/mL complete inhibition).While Taxol also had strong inhibition effect at concentration from 1-10 ng/mL(57% inhibition at 1 ng/mL). Conclusions Low dose doxycyclin,rapamycin,NAC or avandia alone has no antiangiogenic effect,while NS398 presents medium,and suramin or taxol has strong antiangiogenic effects.